Botanical species · safety record

Galium aparine

The EFSA Compendium of Botanicals holds 3 constituent measurements for Galium aparine. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Galium aparine L.

3Constituent measurements
0Safety records
1Cited sources
96Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 96 licensed products naming Galium aparine as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Fresh

Source material stated

  • Aerial parts
  • Dried aerial part(s)
  • Dried herb
  • Flowering aerial parts
  • Fresh above ground parts
  • Fresh aerial part collected at flowering time
  • Fresh aerial parts collected at flowering time
  • Fresh aerial parts, collected at flowering time

What the records describe

Constituents measured

  • Harmine1
  • Protopine1
  • Quinazoline alkaloids1

Plant parts

  • Aerial part of plants3

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
HarmineAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
ProtopineAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Quinazoline alkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Sener, Bilge., Ergun, Fatma. Isolation and structural studies on the alkaloids of Galium aparine L. Gazi universitesi eczacilik fakultesi dergisi, 1988, p. 33-40.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue